Thomas Smegal
Analyst · Evercore ISI
Thanks, Dave, and welcome, everyone, to our second quarter earnings call. Just as a preface, I think most of you who are on the call are aware that the major factor for the company in this quarter is the -- really the same as it was in the first quarter and that is that we have not received either a proposed decision or a decision on our California General Rate Case, which was expected prior to January 1, 2020. I am going to begin the results discussion on slide eight of the deck and talk a little bit about the quarter and then on the year-to-date basis and then go on from there. For the second quarter, I will start at slide eight, our net income decreased by $11.7 million to $5.3 million and that is a difference from a $0.35 gain in the second quarter of 2019 to an $0.11 gain in the second quarter of 2020. The big factor here is that we had no rate relief from the California Commission and we estimate that if the rate relief would come in, there is two big factors here and it’s the same two factors we talked about on the first quarter call. There is a total of $29.1 million that we believe would have been achieved versus additional pre-tax income if the Commission has rendered a decision on a favorable basis to the company. And of that, for the second quarter, $10.9 million represents the pure delay of resulting from the settlement agreement that the company filed with the consumer advocate back in October of 2019 and so that is being tracked in an interim rate memorandum account for future recovery. And then $18.2 million, which represents income from our disputed cost recovery regulatory mechanisms. And those remember are mechanisms that we have had for many years, first of all, to decouple our sales from revenue, we will talk quite a bit more about that later in the call, and then secondly, our regulatory mechanism for the pension and healthcare balancing accounts. Because those are in dispute in the case, we didn’t record them as we would normally have and had we recorded them in the quarter, we estimate an additional revenue of -- would have been $18.2 million. Those regulatory mechanisms match up to some cost increases that we had in the quarter. We had $6.5 million of increased water production expenses, of which $5.7 million would have been offset by those regulatory mechanisms and we had $2.1 million of increased pension benefit expenses, which also would have been offset by those regulatory mechanisms had they have been in place. Other factors for the quarter, we saw a rebound in our unrealized benefit plan investment performance that was $3 million higher than in the second quarter of 2019. And other things that happened, which would be typical of a utility company in our situation, our depreciation expense went up very similar to the first quarter, so it was up $2.2 million in the second quarter and that’s related to increased plant investments in 2019 and we did have an increase in our maintenance costs of about $1 million. Turning to slide nine, on a year-to-date basis, very similar story and very similar explanation, the numbers are different, but the explanation is the same. So our net income decreased by $24.4 million to a loss of $15 million on a year-to-date basis. In terms of earnings per share, we have a loss of $0.31 per year-to-date, as compared to a gain of $0.19 in 2019. But again the two factors related to the rate case, we believe that had a rate case been adopted and it was favorable to the company on these matters. The $19.8 million representing the delay of the settlement agreement amounts and $26 million related to our regulatory balancing accounts that we have been discussing. For the year-to-date basis, our unrealized benefit plan investment performance was $4 million lower than in the first half of 2019 and that’s really due to a comparatively strong market conditions in the first quarter of 2019. And other impacts on a year-to-date basis, again very similar, we see depreciation expense increase $4.3 million and maintenance expense increase $1.6 million. On slide 10, this is a very similar slide to what we gave you in the first quarter earnings deck. Our opinion of the estimated benefit from -- on a full year basis from the California GRC has not changed. As shown in the table on that chart, we believe the benefit is between $38.9 million at $42.2 million on an annual basis and so we continue to expect that when we get a decision in the case that that will be the benefit to the company. Our 2020 sales forecast, as we mentioned in last quarter, are about 7% lower than the 2019 adopted sales. So in discussion of the WRAM and the MCBA, we believe that we are much more likely to be closer to adopted sales than we were in 2019. And as I mentioned earlier, we would have been allowed to record additional revenue of $5.6 million to $10.9 million in the second quarter if the settlement had have been adopted, with the low end of the revenue range linked with $5.2 million reduction in depreciation expense. So, getting a little bit more granular on slide 11 on the disputed GRC items, I just wanted to point out that the two things that are the WRAM and the MCBA, we believe that on the -- in the second quarter that’s about $14.9 million that would have been recorded in those balancing accounts, and the pension and medical cost balancing accounts we believe would have been $3.3 million. And again, we are highly confident that past amounts that are recorded in those accounts are recoverable regardless of the Commission’s decision on a go-forward basis in our current General Rate Case. And the other disputed items in the rate case, we don’t believe are major factors in either the second quarter or the year-to-date results. The pages have stopped working, I am going to skip the EPS bridges that we have because those are described in the narrative. And I am going to turn it over to Marty for an update on COVID-19.